Dr RR Baliga's "Got Knowledge Doc" Podkast

"The Evolution of Cancer and Ageing: A History of Constraint" (Nature Reviews Cancer). Fascinating perspective on how tumour suppression mechanisms that protect us early in life may ironically fuel age-related decline later on. ⚖️

From telomeres 🧬 to stem cells 🌱, and from mole rats 🐀 to tortoises 🐢, evolution has shaped a delicate trade-off between cancer resistance and ageing phenotypes. Interventions like rapamycin 💊 and caloric restriction 🥗 remind us that biology is a balancing act between growth, survival, and longevity ⏳.

A reminder that in medicine and science, progress often lies in understanding these evolutionary compromises 🌍💡.

#Cancer #Ageing #Longevity #Evolution #PrecisionMedicine

🌍 Cardiovascular disease (CVD) remains the leading global killer.

📊 In 2023, CVD caused 19.2M deaths and 437M DALYs (JACC).

🔮 By 2050, projections show 35.6M deaths and 1.14B cases (EJPC) — driven by ageing, hypertension, obesity, and dysglycemia.

⚠️ While age-standardized mortality is projected to fall 30%, the absolute burden will nearly double, with the steepest rise in South & East Asia.

✅ Urgent need for region-specific prevention, hypertension control, and equitable health systems to meet this challenge.

💡 The message is clear: we must act today to bend the curve for 2050. ❤️

#JACC #EJPC #GlobalHealth #Cardiology #CVD #Prevention #FutureHealth

🌍 50,000 years of India's evolutionary history 🇮🇳🧬

New genomic research sequencing 2,762 individuals across India reveals:

✨ A major migration out of Africa ~50,000 years ago

🦴 1–2% ancestry from Neanderthals & Denisovans

🔗 Strong founder effects & endogamy raising recessive disease risk

🧩 >160,000 novel variants unique to India, some linked to immunity & drug response

These findings highlight why India's genetic diversity must be central to global precision medicine 💊🔬

#Genomics #India #PrecisionMedicine #EvolutionaryHistory

💉 RSV Vaccines: From NEJM to JAMA, Lungs to Heart! ❤️🫁

Evidence is converging—NEJM, DAN-RSV Trial 🇩🇰, CDC real-world study 🇺🇸, and a powerful JAMA editorial 📰—that bivalent RSV vaccines protect not just against severe respiratory illness but may also lower cardiorespiratory hospitalizations in older adults 👵👴.

A new frontier where infection prevention meets cardiovascular health 🌍✨ Kudos to Dr. Tor Biering-Sørensen & Dr. Helen Chu for leading the way! 🙌

#RSV #Vaccines #NEJM #JAMA #Cardiology #PublicHealth #Prevention

🔍 William of Ockham (c.1287–1347), the Franciscan friar & philosopher, gave us Occam's Razor ✂️—the call to seek the simplest, most evidence-based explanations.

His logic, nominalism & challenge to authority echo in today's science, ethics & healthcare 🩺📜.

A reminder for providers: clarity, parsimony & humility in reasoning can guide better care. 🌍✨ #Wisdom #Healthcare

🦠💉 Five landmark studies shed new light on influenza vaccines!

🇪🇸 GALFLU (Spain, NEJM): High-dose vaccine cut influenza/pneumonia hospitalizations.

🇩🇰 DANFLU-2 (Denmark, NEJM & JAMA): Neutral primary outcome but signals for fewer CV & HF hospitalizations.

🇨🇳 PANDA II (China, Lancet): In-hospital vaccination lowered mortality & readmissions in acute HF.

📊 JAMA Editorial by Robert Califf: Calls for a true learning health system.

✨ Together, they show small gains per patient can yield huge public health wins!

🌟 New insights into extreme longevity! 🌟

Our latest read on the multiomics blueprint of a 117-year-old supercentenarian reveals how genetics 🧬, metabolism ⚡, microbiome 🌱, and epigenetics 🕰️ can decouple aging from disease.

📊 Findings:

• Ultra-short telomeres but no cancer 📉

• Protective genetic variants and robust mitochondria 💪

• Efficient lipid metabolism (high HDL, low triglycerides) 💧

• Low inflammation 🔥

• Youth-like microbiome (rich in Bifidobacterium) 🦠

• Epigenetic age decades younger than chronological age ✨

⚠️ Limitations: single-subject study, but a powerful window into healthy aging.

💡 Takeaway: Longevity isn't just about adding years — it's about adding healthy years. This work opens doors for biomarkers and interventions that could redefine aging.

#Longevity #Multiomics #HealthyAging #PrecisionMedicine #Epigenetics

🚨 New Evidence Alert 🚨

The SWEDEPAD 1 & 2 trials + a powerful Lancet commentary have reshaped how we view paclitaxel-coated devices in peripheral artery disease.

👉 No benefit for amputation or quality of life.

👉 A concerning signal for higher 5-year mortality in claudication.

👉 Registry-based RCTs prove invaluable for real-world insights.

⚖️ Message: Harm may outweigh benefit — time to rethink strategies and explore alternatives like sirolimus.

#PAD #ClinicalTrials #Cardiology #SWEDEPAD 🫀

🚨 Breakthrough in Huntington's Disease 🧬🧠✨

Exciting results from the pivotal Phase I/II AMT-130 gene therapy trial show a 75% slowing of disease progression at 36 months compared to controls. Key functional and cognitive endpoints (cUHDRS, TFC, SWRT, SDMT) also demonstrated significant benefit, alongside biomarker reduction in CSF neurofilament light chain 📊🔑.

💉 Delivered via precision stereotactic neurosurgery, AMT-130 was well-tolerated and shows clear evidence of a dose–response effect. A BLA submission is planned for 2026, potentially marking a landmark shift in Huntington's disease care.

🌍 For patients and families living with HD, these results provide long-awaited hope.

#HuntingtonsDisease #GeneTherapy #ClinicalTrials #Neurology #PrecisionMedicine #Innovation 🚀

🚨 GLP-1 Medicines: Beyond Diabetes! 💉🧠💪

From weight loss to brain health, the future of GLP-1 therapies is unfolding fast! 🌍✨

New agents like retatrutide and MariTide are redefining outcomes in obesity, neurodegeneration, and substance use disorders.

🔬 Oral options, muscle-sparing combos, and triple agonists are here.

🧪 Dive into 15+ FAQs from the latest JAMA 2025 Perspective — formatted with emojis, clinical pearls, and clear takeaways.

📥 Message me if you'd like the .pptx version!

#GLP1 #Tirzepatide #Semaglutide #ObesityCare #NeuroEndocrine #JAMA #PrecisionMedicine #PharmaInnovation #Endocrinology #MetabolicHealth #LinkedInLearning